Overview

Study on Cognitive Disorders of Multiple Sclerosis

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if memantine is effective in the treatment on cognitive disorders of Relapsing - Remitting multiple sclerosis. m
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Caen
Collaborators:
H. Lundbeck A/S
Ministry of Health, France
Treatments:
Memantine